Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

10X Genomics Inc (TXG)

10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,355,152
  • Shares Outstanding, K 126,553
  • Annual Sales, $ 610,790 K
  • Annual Income, $ -182,630 K
  • EBIT $ -91 M
  • EBITDA $ -48 M
  • 60-Month Beta 2.24
  • Price/Sales 3.58
  • Price/Cash Flow N/A
  • Price/Book 2.85

Options Overview Details

View History
  • Implied Volatility 91.20% (-8.36%)
  • Historical Volatility 60.27%
  • IV Percentile 79%
  • IV Rank 52.72%
  • IV High 127.16% on 04/23/25
  • IV Low 51.09% on 08/21/25
  • Expected Move (DTE 12) 2.87 (15.44%)
  • Put/Call Vol Ratio 0.19
  • Today's Volume 420
  • Volume Avg (30-Day) 627
  • Put/Call OI Ratio 0.29
  • Today's Open Interest 9,632
  • Open Int (30-Day) 9,713
  • Expected Range 15.74 to 21.48

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.19
  • Number of Estimates 8
  • High Estimate -0.06
  • Low Estimate -0.27
  • Prior Year -0.40
  • Growth Rate Est. (year over year) +52.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.37 +7.14%
on 02/05/26
23.56 -21.01%
on 01/23/26
-0.70 (-3.63%)
since 01/06/26
3-Month
13.58 +37.04%
on 11/07/25
23.56 -21.01%
on 01/23/26
+5.61 (+43.15%)
since 11/06/25
52-Week
6.78 +174.48%
on 04/07/25
23.56 -21.01%
on 01/23/26
+3.96 (+27.03%)
since 02/06/25

Most Recent Stories

More News
PharosAI and 10x Genomics Partner to Transform Cancer Research with AI and Spatial Biology

Initiative will create one of the world's largest multimodal cancer datasets and an integrated suite of AI models and tools to fuel precision medicine

TXG : 18.61 (+5.14%)
1 Momentum Stock to Target This Week and 2 We Turn Down

1 Momentum Stock to Target This Week and 2 We Turn Down

SITE : 150.01 (+1.34%)
TXG : 18.61 (+5.14%)
NIC : 152.25 (+1.35%)
Cathie Wood Just Bet $26 Million on Broadcom Stock. Should You Buy AVGO Too?

Cathie Wood bets on Broadcom while shorting major market names in a week of activity.

BLSH : 27.45 (+10.24%)
ARKX : 31.69 (+5.56%)
NFLX : 82.20 (+1.64%)
META : 661.46 (-1.31%)
ROKU : 85.85 (-0.23%)
TXG : 18.61 (+5.14%)
GTLB : 32.13 (+4.97%)
AVGO : 332.92 (+7.22%)
TWST : 49.24 (+4.54%)
ILMN : 119.72 (-10.40%)
CRCL : 57.04 (+13.56%)
WRD : 7.81 (+6.11%)
3 Small-Cap Stocks We’re Skeptical Of

3 Small-Cap Stocks We’re Skeptical Of

TXG : 18.61 (+5.14%)
SPT : 8.00 (+1.39%)
FIGS : 10.74 (+1.23%)
3 Cash-Producing Stocks That Fall Short

3 Cash-Producing Stocks That Fall Short

TECH : 66.78 (+1.40%)
TXG : 18.61 (+5.14%)
DHI : 156.27 (-1.18%)
10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026

PLEASANTON, Calif. , Jan. 22, 2026 /PRNewswire/ -- 10x Genomics, Inc.  (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the fourth...

TXG : 18.61 (+5.14%)
3 Unprofitable Stocks with Warning Signs

3 Unprofitable Stocks with Warning Signs

AAP : 55.30 (+4.48%)
TXG : 18.61 (+5.14%)
CCOI : 24.29 (+7.72%)
3 Hyped Up Stocks That Concern Us

3 Hyped Up Stocks That Concern Us

TXG : 18.61 (+5.14%)
SF : 130.61 (+2.01%)
NTRS : 152.15 (+3.17%)
1 Healthcare Stock to Consider Right Now and 2 We Find Risky

1 Healthcare Stock to Consider Right Now and 2 We Find Risky

TXG : 18.61 (+5.14%)
ABT : 110.83 (+1.60%)
OCUL : 9.16 (+2.81%)
1 Cash-Heavy Stock to Consider Right Now and 2 We Question

1 Cash-Heavy Stock to Consider Right Now and 2 We Question

DDS : 666.51 (+4.88%)
TXG : 18.61 (+5.14%)
ISRG : 488.15 (+2.48%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California.

See More

Key Turning Points

3rd Resistance Point 19.99
2nd Resistance Point 19.35
1st Resistance Point 18.98
Last Price 18.61
1st Support Level 17.97
2nd Support Level 17.33
3rd Support Level 16.96

See More

52-Week High 23.56
Last Price 18.61
Fibonacci 61.8% 17.15
Fibonacci 50% 15.17
Fibonacci 38.2% 13.19
52-Week Low 6.78

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar